James reason: patient safety, human error, and swiss cheese.
Summary of "James reason: patient safety, human error, and swiss cheese."
No Summary Available
Affiliation
Medical Management Centre/LIME, Karolinska Institutet, Stockholm, Sweden; and Southwest Hospital District of Finland, Turku, Finland.
Journal Details
This article was published in the following journal.
Name: Quality management in health care
ISSN: 1550-5154
Pages: 59-63
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22207020
- DOI: http://dx.doi.org/10.1097/QMH.0b013e3182418294
Medical and Biotech [MESH] Definitions
Refusal To Treat
Refusal of the health professional to initiate or continue treatment of a patient or group of patients. The refusal can be based on any reason. The concept is differentiated from PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL which originates with the patient and not the health professional.
Lactobacillus Casei
A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina.
Product Recalls And Withdrawals
The removal of a consumer product from the market place. The reason for the removal can be due a variety of causes, including the discovery of a manufacturing defect, a safety issue with the product's use, or marketing decisions.
Swiss 3t3 Cells
A cell line established in 1962 from disaggregated Swiss albino mouse embryos. This fibroblast cell line is extremely popular in research.
Safety
Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.
PubMed Articles
Time Course and Specificity of Lipolysis in Swiss Cheese.
Controlling lipolysis in cheese is necessary to ensure the formation of desirable flavor. To get a better understanding of the mechanism of lipolysis in Swiss cheese, cheeses were manufactured with an...
Background Various authorities recommend the participation of patients in promoting patient safety, but little is known about health care professionals' (HCPs') attitudes towards patients' involvem...
Patient safety - definition and epidemiology of adverse events, errors and incidents.
Multiple studies in the last years on patient safety brought this issue into focus for healthcare workers, but also politics and public. It is evident, that patient safety in health care is not longer...
CIRRNET® - learning from errors, a success story.
CIRRNET® is the network of local error-reporting systems of the Swiss Patient Safety Foundation. The network has been running since 2006 together with the Swiss Society for Anaesthesiology and Resusc...
Patient safety in outpatient care - study of Swiss primary care offices.
Knowledge of the most frequent and relevant safety problems is necessary in order to identify areas of risk in patient safety and to specify need for action. For Switzerland, there was no data availab...
Clinical Trials
Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
This purpose of this study is to perform a pilot investigation to determine if opioid peptides such as casomorphin can be detected in human plasma after cheese ingestion.
The aim of this study is to examine if a diet rich in cheese will have a beneficial effect on risk markers of cardiovascular disease compared to a diet rich in butter. The primary paramet...
The Effects of the Swiss Ball on Cerebral Vascular Accident
The objective of this study was to investigate the effects of the Swiss ball on patients with hemiplegia due to CVA.
Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry
The clinical and radiological data of patients with an acute ischemic stroke treated with intravenous thrombolysis (IVT) or intraarterial thrombolysis (IAT) in a Swiss stroke unit are asse...
A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol
The proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) across starting doses of 10 mg, 20 mg, 40 mg, and 80 mg of atorvast...
